Table 2 Diagnostic performance of preoperative TRUS and mpMRI for localization of prostate cancer in the 348 segmental regions in the studied 58 patients

Cancer site (number)

 Right base

40

49

47

 Right mid-zonal

31

43

43

 Right apex

1

6

4

 Left base

12

27

27

 Left mid-zonal

7

18

18

 Left apex

0

4

4

 Total

89

147

143

Test + ve

Test − ve

Test + ve

Test − ve

82

61

142

1

143

True + ve

7

198

5

200

205

True − ve

Sensitivity (%)

57.34 (95% CI 48.81–65.57)

99.30 (95% CI 96.17–99.98)

Specificity (%)

96.59 (95% CI 93.09–98.62)

97.56 (95% CI 94.40–99.20)

Positive PV (%)

92.13 (95% CI 84.46–96.78)

96.60 (95% CI 92.24–98.89)

Negative PV (%)

76.45 (95% CI 70.80–81.48)

99.50 (95% CI 97.26–99.99)

Positive LHR

16.79 (95% CI 08.00–35.26)

40.71 (95% CI 17.13–96.78)

Negative LHR

00.44 (95% CI 00.36–00.54)

00.01 (95% CI 00.00–00.05)

AUC

00.77 (95% CI 00.72–00.81)

00.98 (95% CI 00.96–00.99)